These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8097808)

  • 1. Diagnosis of symptomless left ventricular dysfunction.
    Barnett DB
    Lancet; 1993 May; 341(8853):1124-5. PubMed ID: 8097808
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis of symptomless left ventricular dysfunction.
    Tan LB; Hall A
    Lancet; 1993 Jul; 342(8863):116-7. PubMed ID: 8100883
    [No Abstract]   [Full Text] [Related]  

  • 3. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Cheung B
    Br Heart J; 1995 Jun; 73(6):584-5. PubMed ID: 7626365
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ACE inhibitors on the atrial natriuretic peptides in heart failure.
    Struthers AD
    Br Heart J; 1994 Dec; 72(6):504. PubMed ID: 7857729
    [No Abstract]   [Full Text] [Related]  

  • 5. Natriuretic peptides in detection of heart failure.
    Dickstein K
    Lancet; 1998 Jan; 351(9095):4. PubMed ID: 9433417
    [No Abstract]   [Full Text] [Related]  

  • 6. [Recommendations for the clinical use of cardiac natriuretic peptides].
    Emdin M; Clerico A; Clemenza F; Galvani M; Latini R; Masson S; Mulè P; Panteghini M; Valle R; Zaninotto M; Ganau A; Mariotti R; Volpe M; Aspromonte N; Cacciatore G; Cappelletti P; L'Abbate A; Miglio F; Ottani F; Pagani F; Passino C; Plebani M; Sarzani R; Zucchelli G
    Ital Heart J Suppl; 2005 May; 6(5):308-25. PubMed ID: 15934430
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessment of heart failure with plasma natriuretic peptides.
    McMurray J; Davie AP; McClure SJ
    Lancet; 1998 Feb; 351(9100):444; author reply 445. PubMed ID: 9482327
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of heart failure with plasma natriuretic peptides.
    Penney MD; Hampton D
    Lancet; 1998 Feb; 351(9100):444; author reply 445. PubMed ID: 9482328
    [No Abstract]   [Full Text] [Related]  

  • 9. Increased plasma levels of brain natriuretic peptide in patients with isolated diastolic dysfunction.
    Lang CC; Prasad N; McAlpine HM; Macleod C; Lipworth BJ; MacDonald TM; Struthers AD
    Am Heart J; 1994 Jun; 127(6):1635-6. PubMed ID: 8197998
    [No Abstract]   [Full Text] [Related]  

  • 10. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
    Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
    Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction.
    Lerman A; Gibbons RJ; Rodeheffer RJ; Bailey KR; McKinley LJ; Heublein DM; Burnett JC
    Lancet; 1993 May; 341(8853):1105-9. PubMed ID: 8097801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for using a blood sample in the diagnosis of heart failure.
    Struthers AD
    QJM; 1995 May; 88(5):303-6. PubMed ID: 7796082
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in plasma cardiac natriuretic peptides concentrations during 1 year treatment with angiotensin-converting enzyme inhibitor in elderly hypertensive patients with left ventricular hypertrophy.
    Kohno M; Yokokawa K; Yasunari K; Kano H; Minami M; Hanehira T; Yoshikawa J
    Int J Clin Pharmacol Ther; 1997 Jan; 35(1):38-42. PubMed ID: 9021441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical detection of left-ventricular systolic dysfunction.
    McDonagh TA; Robb SD; Murdoch DR; Morton JJ; Ford I; Morrison CE; Tunstall-Pedoe H; McMurray JJ; Dargie HJ
    Lancet; 1998 Jan; 351(9095):9-13. PubMed ID: 9433422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrial natriuretic peptide as a marker of heart failure in children with left ventricular volume overload.
    Kotby AA; Taman KH; Sedky HT; Habeeb NM; El-Hadidi ES; Yosseif HS
    J Paediatr Child Health; 2013 Jan; 49(1):43-7. PubMed ID: 23279037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine excitation in heart failure.
    Riegger AJ
    Br Heart J; 1994 Aug; 72(2 Suppl):S28-30. PubMed ID: 7946753
    [No Abstract]   [Full Text] [Related]  

  • 18. The natriuretic peptides in heart failure.
    Nicholls MG
    J Intern Med; 1994 Jun; 235(6):515-26. PubMed ID: 8207359
    [No Abstract]   [Full Text] [Related]  

  • 19. [Atrial natriuretic factor and brain natriuretic peptide. Variations in elderly subjects with heart failure].
    Tissandier O; Nasr A; Rainfray M; Hamon-Vilcot B; Piette F
    Presse Med; 1995 Dec; 24(38):1837-41. PubMed ID: 8545437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Human atrial natriuretic peptide (hANP), human brain natriuretic peptide (hBNP)].
    Tsujino M; Hirata Y
    Nihon Rinsho; 1995 Mar; 53 Su Pt 2():737-40. PubMed ID: 8753347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.